Drug Profile
Research programme: gabapentin/pregabalin/tapentadol/tramadol - Grunenthal
Alternative Names: NPRx-300; PRTT-100Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ProTect Pharmaceuticals
- Class Amines; Aminobutyric acids; Analgesics; Cyclohexanecarboxylic acids; Cyclohexanols; Dimethylamines; Phenols; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Alpha 2 adrenergic receptor antagonists; CACNA2D1 protein modulators; GABA receptor agonists; Opioid mu receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pain in USA (PO, Controlled release)
- 26 Apr 2010 Early research in Pain in USA (PO)